Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × FluLaval × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Myelodysplastic Syndromes 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Glioma 1 Astrocytoma 1

Interventions

Cyclophosphamide 388 Rituximab 339 Etoposide 194 Vincristine 182 Filgrastim 176 Doxorubicin 171 Prednisone 146 Radiotherapy 138 Cytarabine 138 fludarabine phosphate 124 Methotrexate 117 Melphalan 113 Peripheral Blood Stem Cell Transplantation 108 fludarabine 104 Busulfan 86 Dexamethasone 77 Carmustine 65 Granulocyte Colony-Stimulating Factor 62 Tacrolimus 60 Whole-Body Irradiation 56 Mycophenolic Acid 56 Gemcitabine 56 Bendamustine Hydrochloride 56 Antilymphocyte Serum 55 Lenalidomide 53 Ifosfamide 51 Cyclosporine 51 Bortezomib 49 Methylprednisolone 43 Leucovorin 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡